The 10th World Cancer Congress (WCC) – 2027 features comprehensive, multidisciplinary scientific tracks designed to address early detection, screening, cancer prevention, and precision oncology. Each track brings together global expertise from research, clinical practice, public health, and innovation.
Population-based screening programs, early diagnosis strategies, risk stratification models, and implementation science.
Lifestyle modification, tobacco control, infection-related cancers, HPV & HBV vaccination, chemoprevention, and environmental risk factors.
Global cancer burden, surveillance systems, health equity, policy development, and national cancer control programs.
Genomics, proteomics, epigenetics, liquid biopsy, early detection biomarkers, and companion diagnostics.
Hereditary cancer syndromes, genetic counseling, polygenic risk scores, and personalized screening strategies.
AI-assisted imaging, machine learning in diagnostics, digital pathology, big data analytics, and decision-support systems.
Breast, cervical, lung, colorectal, oral, prostate, gynecologic, gastrointestinal, and pediatric cancers.
Patient-centered care, psycho-oncology, rehabilitation, quality of life, and survivorship planning.
Bench-to-bedside research, early-phase trials, real-world evidence, and clinical implementation of innovations.